In 2017 the following case study was distributed to ECAT participants:
A plasma sample is sent in to a spezialized coagulation lab from a some miles distant operation center. A patient with severe hemophilia is scheduled for an emergency intervention. 3000 Units factor VIII concentrate have been applied 1h before the intervention to normalise FVIII plasma levels, the compound however has not been declared in the protocol. Also the type of hemophilia is not declared.
Unfortunately the medical doctor sending in the blood sample for detailed coagulation testing is not available because he is in the operation theatre.
How would you proceed?
The sample used in this case study survey was from a patient with haemophilia A who is treated with Refacto.